CIK 0001232524
- Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- EIN
- 981032470
- Phone
- +353 16347800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-05 | Patil Neena M CLO&SVP Legal and Corp Affairs | Shares withheld for taxes | −993 | $148.49 | $147K | 25,233 |
| 2021-08-05 | COZADD BRUCE C Chairman & CEO | Option exercise | +2,652 | $46.83 | $124K | 309,790 |
| 2021-08-05 | COZADD BRUCE C Chairman & CEO | Option exercise · Incentive Stock Option (right to buy) | −2,652 | 0 | ||
| 2021-08-02 | COZADD BRUCE C Chairman & CEO | Sale | −1,500 | $169.98 | $255K | 307,388 |
| 2021-08-02 | COZADD BRUCE C Chairman & CEO | Sale | −250 | $170.00 | $43K | 307,138 |
| 2021-07-29 | Winningham Rick E Director | Grant or award | +2,246 | 8,444 | ||
| 2021-07-29 | Sohn Catherine A. Director | Grant or award | +2,246 | 12,868 | ||
| 2021-07-29 | Smith Mark Douglas Director | Grant or award | +2,246 | 4,836 | ||
| 2021-07-29 | RIEDEL NORBERT G Director | Grant or award | +2,246 | 11,705 | ||
| 2021-07-29 | ORiordan Anne Director | Grant or award | +2,246 | 9,711 | ||
| 2021-07-29 | O'Keefe Kenneth W Director | Grant or award | +2,246 | 20,913 | ||
| 2021-07-29 | Mulligan Seamus Director | Grant or award | +2,246 | 1,157,739 | ||
| 2021-07-29 | McSharry Heather Ann Director | Grant or award | +2,246 | 12,579 | ||
| 2021-07-29 | Gray Peter Director | Grant or award | +2,246 | 14,266 | ||
| 2021-07-29 | ENRIGHT PATRICK G Director | Grant or award | +2,246 | 22,614 | ||
| 2021-07-29 | Cook Jennifer E. Director | Grant or award | +2,246 | 4,836 | ||
| 2021-07-01 | COZADD BRUCE C Chairman & CEO | Sale | −10,850 | $180.67 | $2.0M | 308,888 |
| 2021-06-05 | Iannone Robert EVP R&D, Chief Medical Officer | Shares withheld for taxes | −1,206 | $176.47 | $213K | 29,086 |
| 2021-06-05 | Sablich Kim EVP & GM, North America | Shares withheld for taxes | −1,452 | $176.47 | $256K | 23,883 |
| 2021-06-01 | COZADD BRUCE C Chairman & CEO | Sale | −1,750 | $179.07 | $313K | 319,738 |
Page 32 of 39 · 780 trades